Hélène Labussière

1.0k citations

44 papers · 451 indexed · h-index 11

Hematology top 5%
- Hematopoietic Stem Cell Transplantation 16
- Acute Myeloid Leukemia Research 11
- Chronic Myeloid Leukemia Treatments 9
- Multiple Myeloma Research and Treatments 4
Genetics top 10%
- Chronic Lymphocytic Leukemia Research 7
Transplantation top 10%
Rheumatology
Oncology
- Neutropenia and Cancer Infections 7
Public Health, Environmental and Occupational Health
- Acute Lymphoblastic Leukemia research 8
Infectious Diseases
- Antifungal resistance and susceptibility 4

Co-authors: Franck E. Nicolini Delphine Réa Phillipp D. Le Coutre Luciano Levato Ivo Buschmann Mauricette Michallet Hervé Dombret Francis J. Giles
Cited by: Hematology Genetics Transplantation
Journals: Blood (18 papers)Cancer (1 paper)Leukemia (1 paper)
Partner nations: France Belize Spain

In The Last Decade

Hélène Labussière

42 papers receiving 444 citations

Peers

Countries citing papers authored by Hélène Labussière

Since Specialization

Citations

This map shows the geographic impact of Hélène Labussière's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hélène Labussière with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hélène Labussière more than expected).

Fields of papers citing papers by Hélène Labussière

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hélène Labussière. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hélène Labussière. The network helps show where Hélène Labussière may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hélène Labussière, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hélène Labussière Line = papers co-authored together Hélène Labussière links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Ruxolitinib stopped before transplantation does not induce cytokine release in myelofibrosis Cancer Immunology Immunotherapy ·Sara Villar,Emmanuel Curis,Marie‐Hélène Schlageter,Nelly Bosselut,A Charbonnier,Marie‐Thérèse Rubio,Pascal Turlure,Hélène Labussière,Jacques‐Olivier Bay,Jérôme Cornillon,Laure Vincent,Corentin Orvain,Jean‐Jacques Kiladjian,David Michonneau,Gèrard Socié,Marie Robin	2025	0
2	Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial Blood Cancer Journal ·Éolia Brissot,Myriam Labopin,Hélène Labussière,Gaëlle Fossard,Patrice Chevallier,Thierry Guillaume,Ibrahim Yakoub‐Agha,Micha Srour,Claude‐Eric Bulabois,Anne Huynh,Sylvain Chantepie,Anne‐Lise Ménard,Marie‐Thérèse Rubio,Patrice Céballos,Rémy Duléry,Sabine Fürst,Florent Malard,Didier Blaise,Mohamad Mohty	2024	12
3	Sickle cell disease and acute leukemia: one case report and an extensive review Annals of Hematology ·Giovanna Cannas,Solène Poutrel,Maël Heiblig,Hélène Labussière,Marie‐Virginie Larcher,Xavier Thomas,A. Hot	2023	7
4	LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Mediterranean Journal of Hematology and Infectious Diseases ·Xavier Thomas,Marica Laurino,Sandrine Loron,Marie-virginie Larcher,Gaëlle Fossard,Mohamed Elhamri,Alexandre Deloire,Marie Balsat,Fiorenza Barraco,Hélène Labussière,Sophie Ducastelle,Myriam Renault,Eric Wattel,Maël Heiblig,Gilles Salles	2020	2
5	Successful and Safe Treatment of Intestinal Graft-Versus-Host Disease (GvHD) with Pooled-Donor Full Ecosystem Microbiota Biotherapeutic: Results from a 29 Patient-Cohort of a Compassionate Use/Expanded Access Treatment Program Blood ·Florent Malard,Michaël Loschi,Faézeh Legrand,Raynier Devillier,Sarah Guenounou,Cécile Borel,Déborah Desmier,Jérôme Cornillon,Amandine Le Bourgeois,Jean-Baptiste Méar,Delphine Martineau,Hélène Labussière,Marie‐Anne Couturier,Claude‐Eric Bulabois,Émilie Plantamura,Mohamad Mohty	2020	4
6	Elderly Patients (Age 70 Years or Older) With Secondary Acute Myeloid Leukemia or Acute Myeloid Leukemia Developed Concurrently to Another Malignant Disease Clinical Lymphoma Myeloma & Leukemia ·Elodie Collinge,Sandrine Loron,Marie‐Virginie Larcher,Mohamed Elhamri,Maël Heiblig,Alexandre Deloire,Sophie Ducastelle,Hélène Labussière,Fiorenza Barraco,Eric Wattel,Gilles Salles,Étienne Paubelle,Xavier Thomas	2018	4
7	Skin allograft for severe chronic GvHD Bone Marrow Transplantation ·Roberto Crocchiolo,Valérie Dubois,F-E Nicolini,Mohamed Sobh,Sophie Ducastelle-Leprêtre,Hélène Labussière,Laure Lebras,Céline Auxenfans,Ali Mojallal,O. Damour,F. Braye,Mauricette Michallet	2017	3
8	Treatment patterns and comparative effectiveness in elderly acute myeloid leukemia patients (age 70 years or older): the Lyon-university hospital experience Leukemia & lymphoma ·Maël Heiblig,Caroline Le Jeune,Mohamed Elhamri,Marie Balsat,Isabelle Tigaud,Adriana Pleșa,Fiorenza Barraco,Hélène Labussière,Sophie Ducastelle,Franck E. Nicolini,Eric Wattel,Gilles Salles,Xavier Thomas	2016	10
9	Using EasyMatch® to anticipate the identification of an HLA identical unrelated donor: A validated efficient time and cost saving method Human Immunology ·Valérie Dubois,Marie Y. Detrait,Mohamad Sobh,Stéphane Morisset,Hélène Labussière,C. Giannoli,Franck E. Nicolini,Philippe Moskovtchenko,Valérie Mialou,Sophie Ducastelle,Sylvie Rey,Xavier Thomas,Fiorenza Barraco,Nathalie Tedone,Évelyne Marry,Federico Garnier,Yves Bertrand,Mauricette Michallet	2016	7
10	Acute graft-versus-host disease, invasive aspergillosis and Clostridium difficile colitis after peripheral blood stem cell transplantation: A complex network of causalities and a challenge for prevention Anaerobe ·Nagham Khanafer,Antoine Neuraz,Thomas Bénet,Martin Cour,Florence Persat,Hélène Labussière,Laurent Argaud,M. Michallet,Philippe Vanhems	2015	2
11	Allogeneic hematopoietic stem cell transplant for hematological malignancies from mismatched 9/10 human leukocyte antigen unrelated donors: comparison with transplants from 10/10 unrelated donors and human leukocyte antigen identical siblings Leukemia & lymphoma ·Mauricette Michallet,Mohamad Sobh,Caroline Serrier,Stéphane Morisset,Hélène Labussière,Sophie Ducastelle,Fiorenza Barraco,Lila Gilis,Xavier Thomas,Franck E. Nicolini	2014	5
12	Peripheral artery occlusive disease in chronic phase chronic myeloid leukemia patients treated with nilotinib or imatinib Leukemia ·T D Kim,Delphine Réa,Michaela Schwarz,Peggy Grille,Franck E. Nicolini,Gianantonio Rosti,Luciano Levato,Francis J. Giles,Hervé Dombret,Tristan Mirault,Hélène Labussière,Ruhdja Lindhorst,Wilhelm Haverkamp,Ivo Buschmann,Bernd Dörken,Phillipp D. Le Coutre	2013	171
13	Evolving strategies with immunomodulating drugs and tandem autologous/allogeneic hematopoietic stem cell transplantation in first line high risk multiple myeloma patients Experimental Hematology ·Mauricette Michallet,Mohamad Sobh,Jean El Cheikh,Stéphane Morisset,Anne Sîrvent,Oumédaly Reman,Jérôme Cornillon,Reza Tabrizi,Nöel Milpied,Jean‐Luc Harousseau,Hélène Labussière,Franck‐Emmanuel Nicolini,Michel Attal,Philippe Moreau,Mohamad Mohty,Didier Blaise,Hervé Avet‐Loiseau	2013	15
14	Impact of anti-HLA antibodies on allogeneic hematopoietic stem cell transplantation outcomes after reduced-intensity conditioning regimens Experimental Hematology ·Marie Y. Detrait,Valérie Dubois,Mohamad Sobh,Stéphane Morisset,Nathalie Tedone,Hélène Labussière,Lilia Gillis,Fiorenza Barraco,Giovanna Cannas,Sophie Ducastelle,Jihane Fatoum,Xavier Thomas,Youcef Chelgoum,Franck‐Emmanuel Nicolini,Mauricette Michallet	2012	21
15	Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients Cancer ·Mauricette Michallet,Karine Goldet,Mohamad Sobh,Stéphane Morisset,Youcef Chelghoum,Xavier Thomas,Fiorenza Barraco,Sophie Ducastelle,Hélène Labussière,C. Renzullo,Carole Paillet,C. Pivot,Perrine Badol‐Van Straaten,Angélique Denis,Anne Termoz,Marie Y. Detrait,Franck‐Emmanuel Nicolini,Isabelle Jaisson‐Hot	2012	13
16	Appréciation quantitative du risque fongique en cas de travaux en établissements de santé : propositions d’indicateurs d’impact des mesures de gestion du risque infectieux fongique Journal de Mycologie Médicale ·Jean‐Pierre Gangneux,Crespin Adjidé,Bernard Le Bonniec,Françoise Botterel,A. Carel,O. Castel,Francis Derouin,Gautier Hoarau,Hélène Labussière,Matthieu Lafaurie,Laurence Millon,B Pottecher,Anne C. M. Thiébaut,M. Turco,Raoul Baron	2012	14
17	Leukocytosis and Circulating Blasts in Older Adults With Newly Diagnosed Acute Myeloid Leukemia: Are They Valuable Factors for Therapeutic Decision-Making? Clinical Lymphoma Myeloma & Leukemia ·Xavier Thomas,Youcef Chelghoum,Giovanna Cannas,Mohamed Elhamri,Hélène Labussière,Isabelle Tigaud,Sophie Ducastelle,Franck E. Nicolini,Charles Dumontet,Mauricette Michallet	2011	7
18	Paroxysmal nocturnal hemoglobinuria and pregnancy before the eculizumab era: the French experience Haematologica ·Sophie de Guibert,Régis Peffault de Latour,Nathalie Varoqueaux,Hélène Labussière,Bernard Rio,Dominique Jaulmes,Jean‐Richard Eveillard,Stéphanie Dulucq,Anne Marie Stoppa,Didier Bouscary,François Girodon,Bernard Bonnotte,D. Laskri,Gèrard Socié,Thierry Lamy	2011	35
19	Invasive aspergillosis: an important risk factor on the short- and long-term survival of acute myeloid leukemia (AML) patients European Journal of Clinical Microbiology & Infectious Diseases ·Mauricette Michallet,Thomas Bénet,Mohamad Sobh,Samira Kraghel,Mohamed El Hamri,Giovanna Cannas,Franck E. Nicolini,Hélène Labussière,Sophie Ducastelle,Fiorenza Barraco,Xavier Thomas,Youcef Chelghoum,Marie‐Christine Nicolle,Anne‐Lise Bienvenu,Florence Persat,Frédérique de Monbrison,Stéphane Picot,Philippe Vanhems	2011	35
20	Analysis of the Molecular Determinants of the Response of Chronic Myelogenous Leukaemia to Tyrosine Kinase Inhibitors Hélène Labussière,Sandrine Hayette,Franck E. Nicolini	2007	1

About Hélène Labussière

Hélène Labussière is a scholar working on Hematology, Transplantation and Genetics, having authored 44 papers that have together received 451 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (16 papers), Acute Myeloid Leukemia Research (11 papers), Chronic Myeloid Leukemia Treatments (9 papers), Acute Lymphoblastic Leukemia research (8 papers), Chronic Lymphocytic Leukemia Research (7 papers), Neutropenia and Cancer Infections (7 papers), Antifungal resistance and susceptibility (4 papers) and Multiple Myeloma Research and Treatments (4 papers). The work is most often cited by research in Hematology (299 citations), Genetics (143 citations) and Transplantation (19 citations). Hélène Labussière has collaborated with scholars based in France, Belize and Spain. Frequent co-authors include Franck E. Nicolini, Delphine Réa, Phillipp D. Le Coutre, Luciano Levato, Ivo Buschmann, Mauricette Michallet, Hervé Dombret, Francis J. Giles, Wilhelm Haverkamp and Bernd Dörken. Their work appears in journals such as Blood, Cancer and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact